Influence of polydispersity on micromechanics of granular materials

We study the effect of polydispersity on the macroscopic physical properties of granular packings in two and three dimensions. A mean-field approach is developed to approximate the macroscale quantities as functions of the microscopic ones. We show that the trace of the fabric and stress tensors are proportional to the mean packing properties (e.g. packing fraction, average coordination number, and average normal force) and dimensionless correction factors, which depend only on the moments of the particle-size distribution. Similar results are obtained for the elements of the stiffness tensor of isotropic packings in the linear affine response regime. Our theoretical predictions are in good agreement with the simulation results.Comment: 13 pages, 13 figures, 2 table

SUSY QCD one-loop effects in (un)polarized top-pair production at hadron colliders

We study the effects of O(alpha_s) supersymmetric QCD (SQCD) corrections on the total production rate and kinematic distributions of polarized and unpolarized top-pair production in pp and p anti-p collisions. At the Fermilab Tevatron p anti-p collider, top-quark pairs are mainly produced via quark-antiquark annihilation, q anti-q -> t anti-t, while at the CERN LHC pp collider gluon-gluon scattering, g g -> t anti-t, dominates. We compute the complete set of O(alpha_s) SQCD corrections to both production channels and study their dependence on the parameters of the Minimal Supersymmetric Standard Model. In particular, we discuss the prospects for observing strong, loop-induced SUSY effects in top-pair production at the Tevatron Run II and the LHC.Comment: 56 pages, 29 figures, RevTeX

Die Welt jenseits der Oszillografen : ein Streitgespräch zwischen dem Hirnforscher Wolf Singer und dem Philosophen Marcus Willaschek

Neurowissenschaftler fordern einen illusionslosen Umgang mit Begriffen wie Willensfreiheit und Bewusstsein. Philosophen kritisieren offen die Thesen von Hirnforschern. Stehen sich diese Positionen unversöhnlich gegenüber? Wo gibt es Möglichkeiten einer Annäherung, gar einer Kooperation? Der Religionsphilosoph Prof. Dr. Thomas M. Schmidt und der Biologe Stefan Kieß loten die Situation in Frankfurt aus; ihre Gesprächspartner sind der Hirnforscher Prof. Dr. Wolf Singer (links), Direktor am Max-Planck-Institut für Hirnforschung, und Prof. Dr. Marcus Willaschek (rechts), Philosoph an der Universität Frankfurt

Non-perturbative effects in semi-leptonic B_c decays

We discuss the impact of the soft degrees of freedom inside the B_c meson on its rate in the semi-leptonic decay B_c -> X l nu_l where X denotes light hadrons below the D^0 threshold. In particular we identify contributions involving soft hadrons which are non-vanishing in the limit of massless leptons. These contributions become relevant for a measurement of the purely leptonic B_c decay rate, which due to helicity suppression involves a factor m_l^2 and thus is much smaller than the contributions involving soft hadrons.Comment: LaTeX, 22 pages, 1 figur

Particle-Particle, Particle-Scaling function (P3S) algorithm for electrostatic problems in free boundary conditions

An algorithm for fast calculation of the Coulombic forces and energies of point particles with free boundary conditions is proposed. Its calculation time scales as N log N for N particles. This novel method has lower crossover point with the full O(N^2) direct summation than the Fast Multipole Method. The forces obtained by our algorithm are analytical derivatives of the energy which guarantees energy conservation during a molecular dynamics simulation. Our algorithm is very simple. An MPI parallelised version of the code can be downloaded under the GNU General Public License from the website of our group.Comment: 19 pages, 11 figures, submitted to: Journal of Chemical Physic

Inhibitor of Apoptosis Proteins as Novel Targets in Inflammatory Processes

Objective: Inhibitor of apoptosis proteins (IAPs), such as X-linked or cellular IAP 1/2 (XIAP, cIAP1/2), are important regulators of apoptosis. IAP antagonists are currently under clinical investigation as anticancer agents. Interestingly, IAPs participate in the inflammation-associated TNF receptor signaling complex and regulate NFκB signaling. This raises the question about the role of IAPs in inflammation. Here, we investigated the anti-inflammatory potential of IAP inhibitors and the role of IAPs in inflammatory processes of endothelial cells. Methods and Results: In mice, the small molecule IAP antagonist A-4.10099.1 (ABT) suppressed antigen-induced arthritis, leukocyte infiltration in concanavalin A-evoked liver injury, and leukocyte transmigration in the TNFα-activated cremaster muscle. In vitro, we observed an attenuation of leukocyte– endothelial cell interaction by downregulation of the intercellular adhesion molecule-1. ABT did not impair NFκB signaling but decreased the TNFα-induced activation of the TGF-β–activated kinase 1, p38, and c-Jun N-terminal kinase. These effects are based on the proteasomal degradation of cIAP1/2 accompanied by an altered ratio of the levels of membrane-localized TNF receptor-associated factors 2 and 5. Conclusion: Our results reveal IAP antagonism as a profound anti-inflammatory principle in vivo and highlight IAPs as important regulators of inflammatory processes in endothelial cells

Moduli-Space Dynamics of Noncommutative Abelian Sigma-Model Solitons

In the noncommutative (Moyal) plane, we relate exact U(1) sigma-model solitons to generic scalar-field solitons for an infinitely stiff potential. The static k-lump moduli space C^k/S_k features a natural K"ahler metric induced from an embedding Grassmannian. The moduli-space dynamics is blind against adding a WZW-like term to the sigma-model action and thus also applies to the integrable U(1) Ward model. For the latter's two-soliton motion we compare the exact field configurations with their supposed moduli-space approximations. Surprisingly, the two do not match, which questions the adiabatic method for noncommutative solitons.Comment: 1+15 pages, 2 figures; v2: reference added, to appear in JHE

An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial

Summary Background With a lifetime risk for major depressive disorder of up to 50%, depression is a common comorbidity in multiple sclerosis but remains widely underdiagnosed and untreated. We investigated the potential of a fully automated, internet-based, cognitive behavioural therapy programme, Deprexis, to reduce depressive symptoms in patients with multiple sclerosis. Methods For this randomised controlled trial, we recruited patients from an outpatient clinic in Hamburg, Germany. Patients aged 18–65 years were eligible for inclusion if they had multiple sclerosis and self-reported depressive symptoms. By use of a computer-generated randomisation sequence, we allocated 90 patients (1:1; no blocking or stratification) to either the intervention group or a waitlist control group for 9 weeks. The primary endpoint was the Beck Depression Inventory (BDI), as assessed by an intention-to-treat analysis. This trial is registered with ClinicalTrials.gov, number NCT01663649. Findings 71 patients completed the trial: 35 patients in the intervention group and 36 patients in the control group. During the intervention, BDI scores decreased in the Deprexis group and increased in the control group, yielding a positive effect of Deprexis relative to the waitlist group (mean group difference –4·02 points [95% CI –7·26 to –0·79], p=0·015, effect size d=0·53). Worsening of depressive symptoms from below to above the clinical cutoff (BDI >13) occurred in three (7%) of 45 patients in the control group and no patients in the Deprexis group. We noted no adverse events with respect to new occurrence of suicidal ideation during the trial. Interpretation Psychological online-intervention programmes could be suitable for patients with multiple sclerosis who are unable to regularly attend therapeutic sessions because of mobility impairments. Funding European Union and the Deutsche Forschungsgemeinschaft

Effect of amoxicillin‐clavulanic acid on clinical scores, intestinal microbiome, and amoxicillin‐resistant Escherichia coli in dogs with uncomplicated acute diarrhea

Background Despite limited evidence of efficacy, antibiotic treatment is still frequently prescribed in dogs with uncomplicated acute diarrhea (AD). Objective To assess whether amoxicillin‐clavulanic acid has a clinical benefit, an effect on the fecal microbiome, and the proportion of amoxicillin‐resistant Escherichia coli in dogs with AD. Animals Sixteen dogs with AD of <3 days duration. Methods Prospective, placebo‐controlled, double‐blinded study. Clinical scores were compared between client‐owned dogs randomly assigned to an antibiotic (AG) or a placebo (PG) group. The intestinal microbiome was analyzed using quantitative PCR assays. Amoxicillin‐resistant fecal E. coli were assessed semiquantitatively with microbiological methods. Results There was no difference in clinical recovery between treated dogs or controls (CADS index day 10: AG group median: 2 (range: 1‐3; CI [1.4; 2.6]); PG group median: 1.6 (range: 1‐3; CI [1.1; 2.4]); P > .99). All dogs gained normal clinical scores (CADS index ≤3) after 1 to 6 days (median 2 days) after presentation. There was no significant difference in the fecal dysbiosis index (during treatment: AG mean −2.6 (SD 3.0; CI [−5.1; 0.0]); PG mean −0.8 (SD 4.0; CI [−4.2; 2.5]; P > .99) or its bacterial taxa. The proportion of resistant fecal E. coli increased (to median: 100%; range: 35%‐100%) during treatment with amoxicillin‐clavulanic acid and was still increased (median: 10%; range 2%‐67%) 3 weeks after treatment, both of which were significantly higher proportions than in the placebo group for both time points (during treatment AG median 100% versus PG median 0.2% (P < .001); after treatment AG median 10% versus PG median 0.0% (P = .002)). Conclusions and Clinical Importance Our study suggests that treatment with amoxicillin‐clavulanic acid confers no clinical benefit to dogs with AD, but predisposes the development of amoxicillin‐resistant E. coli , which persist for as long as 3 weeks after treatment. These findings support international guideline recommendations that dogs with diarrhea should not be treated with antimicrobials unless there are signs of sepsis